CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0060

Trenbolone Enanthate Raw

Filed under Raw Materials. The bureau holds 96 laboratory returns for this compound from 31 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

31 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 10.0 10.0 10 Feb 2026 12 Apr 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 10.0 9.9 10.0 22 Apr 2026 12 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 4 10.0 10.0 10.0 10 Jun 2026 13 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 10.0 10.0 10.0 4 Apr 2026 21 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 3 10.0 9.9 10.0 9 Mar 2026 16 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 10.0 10.0 28 Jun 2026 2 Aug 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 10.0 10.0 10.0 6 Apr 2026 14 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 10.0 10.0 10.0 7 Jan 2026 26 Jun 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 7 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
HomopeptideCASE #VI-2026-0760 A 5 9.9 9.9 10.0 24 May 2026 24 May 2026
Sangon BioCASE #VI-2026-0671 A 4 9.9 9.9 10.0 13 Mar 2026 3 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 9.9 9.9 10.0 25 Mar 2026 26 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 3 9.9 9.9 10.0 7 Nov 2025 27 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 3 9.9 9.9 10.0 4 Jul 2026 10 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 10.0 23 Apr 2026 3 May 2026
BachemCASE #VI-2026-0314 A 2 9.9 9.9 10.0 18 Mar 2026 11 May 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 9.9 5 May 2026 20 May 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 3 Feb 2026 15 May 2026
Sigma-AldrichCASE #VI-2026-0829 A 2 9.9 9.9 10.0 2 Dec 2025 8 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 10.0 24 Jun 2026 1 Aug 2026
SinoPepCASE #VI-2026-0387 A 2 9.9 9.9 10.0 5 Apr 2026 19 Jun 2026
AsymchemCASE #VI-2026-0091 A 2 9.9 9.9 10.0 20 Mar 2026 4 May 2026
AmbioPharmCASE #VI-2026-0177 A 2 9.9 9.9 10.0 25 Feb 2026 22 Jul 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 6 8.8 6.6 10.0 23 May 2026 23 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 7 8.6 8.1 9.8 23 May 2026 23 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 3 8.3 6.7 9.1 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.1 7.3 9.0 25 May 2026 25 May 2026
Shanghai BaojuCASE #VI-2026-0233 X 1 7.7 7.7 7.7 2 Apr 2025 2 Apr 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 2 7.3 7.1 7.6 25 May 2026 25 May 2026
TCICASE #VI-2026-0650 X 1 7.3 7.3 7.3 21 May 2025 21 May 2025
Shaanxi Dideu MedichemCASE #VI-2026-0499 X 1 6.8 6.8 6.8 9 Jun 2025 9 Jun 2025

Open any subject to view the batch-level evidence for Trenbolone Enanthate Raw alone.